name: Escherichia coli aidA-I gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Platelet aggregation.ristocetin induced^750 ug/mL:RelACnc:Pt:PRP:Qn


name: Thymidine synthase activity interpretation:Imp:Pt:Bld/Tiss:Ord


name: Thymidine synthase activity interpretation


name: Brachyspira sp nox gene:Seq:Pt:Isolate:Nom:Sequencing


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.5


name: IRF-PAI v3.0 - Medical information:-:RptPeriod:^Patient:-:CMS Assessment


name: Cytolethal distending toxin B & Vinculin Ab panel:-:Pt:Ser:-:IA


name: Cytolethal distending toxin B & Vinculin Ab panel


name: Cytolethal distending toxin B Ab:ACnc:Pt:Ser:Qn:IA


name: Cytolethal distending toxin B+Vinculin Ab:Imp:Pt:Ser:Ord:IA


name: Borrelia burgdorferi Ab.IgG & IgM panel:-:Pt:CSF:-:IB


name: Cytomegalovirus Ab.IgG & IgM Panel:-:Pt:Ser/Plas:Ord


name: Neutrophil cytoplasmic Ab panel:-:Pt:Ser:-:IF


name: Drugs of abuse screen W Reflex confirm panel:-:Pt:Urine:-


name: Drugs of abuse screen W Reflex confirm panel


name: Hemoglobin.free & oxyhemoglobin panel:-:Pt:Plas:Qn


name: Protein & creatinine panel:-:Pt:Urine:Qn


name: Coccidioides immitis Ab.IgG & IgM panel:-:Pt:Ser/Plas:-


name: Chromosome X & Y aneuploidy:Find:Pt:Bld/Tiss:Doc:FISH


name: Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM:Imp:Pt:XXX:Nom:IA


name: Dengue virus 1+2+3+4 Ab.IgA+IgG+IgM:Imp:Pt:XXX:Ord:IA


name: Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel:-:Pt:XXX:-:IA


name: Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel


name: LCDS v4.00 - Skin conditions - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Mobility - discharge performance:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Mobility - discharge performance


name: LCDS v4.00 - Mobility - admission performance:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Mobility - admission performance


name: Understanding verbal and non-verbal content during 3D assessment period:Find:3D:^Patient:Ord:CMS Assessment


name: Understanding verbal and non-verbal content during 3D assessment period


name: LCDS v4.00 - Administrative information - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Administrative information - discharge


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00


name: Combat zone &or hazardous duty work dates:DateRange:Pt:^Patient:Qn


name: Process of care measures:Find:Pt:{Setting}:Doc:Trauma


name: IRF-PAI v3.0, LCDS v4.00 - Medications - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v3.0, LCDS v4.00 - Medications - admission


name: IRF-PAI v3.0, LCDS v4.00 - Medications - discharge and expired:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v3.0, LCDS v4.00 - Medications - discharge and expired


name: REMS Administrative Information:-:-:^FDA package insert:Nar


name: REMS requirements:-:-:^FDA package insert:Nar


name: REMS participant requirements:-:-:^FDA package insert:Nar


name: REMS applicant requirements:-:-:^FDA package insert:Nar


name: LCDS v4.00 - Spontaneous breathing trial:-:RptPeriod:^Patient:-:CMS Assessment


name: Assessed for readiness for SBT by day 2 of stay:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Invasive mechanical ventilation support upon admission:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Deemed medically ready for SBT by day 2 of stay:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: SBT performed by day 2 of stay:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase with reflex to HEXA gene panel:CCnt:Pt:WBC:-


name: Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase with reflex to HEXA gene panel


name: Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase panel:CCnt:Pt:WBC:-


name: Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase panel


name: Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase panel:-:Pt:Ser/Plas:-


name: Dengue virus Ab.IgG & IgM panel:-:Pt:Ser:Ord


name: Borrelia burgdorferi Ab & Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel:-:Pt:Ser:-


name: Borrelia burgdorferi Ab & Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel


name: Anaplasma phagocytophilum & Ehrlichia sp groEL gene panel:-:Pt:Bld:Ord:Non-probe.amp.tar


name: Anaplasma phagocytophilum & Ehrlichia sp groEL gene panel


name: 1,25-Dihydroxyvitamin D & 1,25-Dihydroxyvitamin D2 & 1,25-Dihydroxyvitamin D3 panel:-:Pt:Ser/Plas:Qn


name: 1,25-Dihydroxyvitamin D & 1,25-Dihydroxyvitamin D2 & 1,25-Dihydroxyvitamin D3 panel


name: Aspergillus fumigatus & Saccharopolyspora rectivirgula & Thermoactinomyces vulgaris Ab.IgG panel:-:Pt:Ser:Qn


name: Aspergillus fumigatus & Saccharopolyspora rectivirgula & Thermoactinomyces vulgaris Ab.IgG panel


name: Sjogrens syndrome-A & B extractable nuclear Ab.IgG panel:-:Pt:Ser:Qn


name: Sjogrens syndrome-A & B extractable nuclear Ab.IgG panel


name: Thyroglobulin & thyroperoxidase Ab panel:-:Pt:Ser/Plas:Qn


name: Thyroglobulin & thyroperoxidase Antibody panel


name: Protein S Ag & protein S Ag.free panel:RelMCnc:Pt:PPP:Qn:IA


name: Anaplasma phagocytophilum groEL gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Ehrlichia chaffeensis groEL gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Ehrlichia canis+ewingii groEL gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Ehrlichia muris eauclairensis groEL gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Candida auris ITS2 gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Bordetella parapertussis IS1001 DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar


name: HEDIS 2018 Value Set - Alcohol Screening:-:Pt:^Patient:-


name: HEDIS 2018 Value Set - Alcohol Screening


name: Plan of care note:Find:Pt:{Setting}:Doc:Brain injury


name: Parent Patient Activation Measure - 13:-:Pt:^Parent:-:PAM


name: When all is said and done, I am the person who is responsible for taking care of my child's health:Find:Pt:^Parent:Ord:PAM


name: Taking an active role in my child's health care is the most important thing that affects his or her health:Find:Pt:^Parent:Ord:PAM


name: I am confident I can help prevent or reduce problems associated with my child's health:Find:Pt:^Parent:Ord:PAM


name: I am confident I can help prevent or reduce problems associated with my child's health


name: I know what each of my child's prescribed medications do:Find:Pt:^Parent:Ord:PAM


name: I know what each of my child's prescribed medications do


name: I am confident that I can tell whether I need to go to the doctor or whether I can take care of my child's health problem myself:Find:Pt:^Parent:Ord:PAM


name: I am confident that I can tell whether I need to go to the doctor or whether I can take care of my child's health problem myself


name: I am confident that I can tell a doctor concerns I have abou my child's health even when he or she does not ask:Find:Pt:^Parent:Ord:PAM


name: I am confident that I can tell a doctor concerns I have abou my child's health even when he or she does not ask


name: I am confident that I can follow through on medical treatments I need to do for my child at home:Find:Pt:^Parent:Ord:PAM


name: I am confident that I can follow through on medical treatments I need to do for my child at home


name: I understand my child's health problems and what causes them:Find:Pt:^Parent:Ord:PAM


name: I understand my child's health problems and what causes them


name: I know what treatments are available for my child's health problems:Find:Pt:^Parent:Ord:PAM


name: I know what treatments are available for my child's health problems


name: I have been able to help my child maintain (keep up with) lifestyle changes, like eating right or exercising:Find:Pt:^Parent:Ord:PAM


name: I have been able to help my child maintain (keep up with) lifestyle changes, like eating right or exercising


name: I know how to prevent problems with my child's health:Find:Pt:^Parent:Ord:PAM


name: I know how to prevent problems with my child's health


name: I am confident I can figure out solutions when new problems arise with my child's health:Find:Pt:^Parent:Ord:PAM


name: I am confident I can figure out solutions when new problems arise with my child's health


name: I am confident that I can help my child maintain lifestyle changes, like eating right and exercising, even during times of stress:Find:Pt:^Parent:Ord:PAM


name: I am confident that I can help my child maintain lifestyle changes, like eating right and exercising, even during times of stress


name: Parent Patient Activation Measure - 10:-:Pt:^Parent:-:PAM


name: When all is said and done, I am responsible for seeing that this person's health is managed properly:Find:Pt:^Caregiver:Ord:PAM


name: Taking an active role in this person's health care is one of the most important factors in determining her or his health and ability to function:Find:Pt:^Caregiver:Ord:PAM


name: I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with this person's health:Find:Pt:^Caregiver:Ord:PAM


name: I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with this person's health


name: I know what each of this person's prescribed medications do:Find:Pt:^Caregiver:Ord:PAM


name: I know what each of this person's prescribed medications do


name: I am confident that I can tell when this person needs to get medical care and when I can handle the problem myself:Find:Pt:^Caregiver:Ord:PAM


name: I am confident that I can tell when this person needs to get medical care and when I can handle the problem myself


name: I am confident I can tell a doctor the concerns that I have about this person's health even when he or she does not ask:Find:Pt:^Caregiver:Ord:PAM


name: I am confident I can tell a doctor the concerns that I have about this person's health even when he or she does not ask


name: I am confident that I can follow through on medical treatments I need to do for this person at home:Find:Pt:^Caregiver:Ord:PAM


name: I am confident that I can follow through on medical treatments I need to do for this person at home


name: I understand the nature and causes of this person's health:Find:Pt:^Caregiver:Ord:PAM


name: I understand the nature and causes of this person's health


name: I know the different medical treatment options available for this person's health:Find:Pt:^Caregiver:Ord:PAM


name: I know the different medical treatment options available for this person's health


name: I am able to help this person maintain lifestyle changes (like eating right or exercising) for her or his condition:Find:Pt:^Caregiver:Ord:PAM


name: I am able to help this person maintain lifestyle changes (like eating right or exercising) for her or his condition


name: I know how to prevent problems with this person's health:Find:Pt:^Caregiver:Ord:PAM


name: I know how to prevent problems with this person's health


name: Multisection for pulmonary embolus+deep vein thrombosis^W contrast IV:Find:Pt:Chest>Pulmonary arteries.bilateral & Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Multisection for pulmonary embolus+deep vein thrombosis:Find:Pt:Chest>Pulmonary arteries.bilateral & Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis>Deep inferior epigastric artery:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen>Mesenteric vessels:Doc:CT.angio


name: Varicella zoster virus DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Escherichia coli oppA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Gram negative bacteria identified:Imp:Pt:Bld.pos growth:Nom:Probe


name: Gram negative blood culture panel:-:Pt:Bld.pos growth:-:Probe


name: I am confident I can figure out solutions when new situations or problems arise with this person's health:Find:Pt:^Caregiver:Ord:PAM


name: I am confident I can figure out solutions when new situations or problems arise with this person's health


name: I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress:Find:Pt:^Caregiver:Ord:PAM


name: I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress


name: Caregiver Patient Activation Measure - 13:-:Pt:^Caregiver:-:PAM


name: Caregiver Patient Activation Measure - 13


name: Caregiver Patient Activation Measure - 10:-:Pt:^Caregiver:-:PAM


name: Caregiver Patient Activation Measure - 10


name: Rotavirus C VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus B VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus A VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus A VP4 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A M gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A HA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Honey bee recombinant (rApi m) 2 IgE RAST class (S)


name: Peanut (Arachis hypogaea) recombinant (rAra h) 6 IgE RAST class (S)


name: Arachis hypogaea recombinant (rAra h) 6 Ab.IgE.RAST class


name: Peanut (Arachis hypogaea) recombinant (rAra h) 5 IgE RAST class (S)


name: Arachis hypogaea recombinant (rAra h) 5 Ab.IgE.RAST class


name: HBA1 & HBA2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: KIT gene exon 17 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 17 targeted mutation analysis


name: KIT gene exon 13 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 13 targeted mutation analysis


name: KIT gene exon 8 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 8 targeted mutation analysis


name: Intravascular diastolic^post exercise:Pres:Pt:Arterial system:Qn


name: GALC gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GALC gene deletion+duplication & full mutation analysis


name: Intravascular systolic^W exercise:Pres:Pt:Arterial system:Qn


name: Intravascular diastolic^W exercise:Pres:Pt:Arterial system:Qn


name: Intravascular systolic^post exercise:Pres:Pt:Arterial system:Qn


name: Clostridioides difficile BI-NAP1-027 strain DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: BMPR1A & SMAD4 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BMPR1A & SMAD4 gene deletion+duplication & full mutation analysis


name: Platelet glycoprotein IV Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Lifetime risk for developing genetic disease assessed:Likelihood:Lifetime:^Patient:Ord


name: Fibroblast growth factor 21.intact:MCnc:Pt:Ser/Plas:Qn


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Hepatic vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Aortic valve:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen>Abdominal veins & Pelvis>Pelvis veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Pulmonary veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary arteries:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Aorta.thoracic:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary arteries+Aorta.thoracic:Doc:CT.angio


name: Multisection:Find:Pt:Pelvis>Pelvis veins & Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Multisection:Find:Pt:Lower extremity>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Renal vessels:Doc:CT.angio


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Chest & Chest>Coronary arteries:Doc:CT && CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Mesenteric vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis && Abdomen>Aorta.abdominal:Doc:CT && CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis && Abdomen>Aorta.abdominal:Doc:CT && CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head+Neck>Circle of Willis+Carotid arteries:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Head+Neck>Circle of Willis+Carotid arteries:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis>Deep inferior epigastric artery:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Abdomen+Pelvis:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Chest+Abdomen:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Chest+Abdomen+Pelvis:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis && Chest+Abdomen+Pelvis:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:CT


name: Multisection by reconstruction^WO & W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Lung parenchyma:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Lower extremity.bilateral>Knee:Doc:CT


name: Multisection^WO contrast:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Thigh:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT


name: Multisection^WO contrast:Find:Pt:Upper extremity.bilateral>Upper arm:Doc:CT


name: Multisection^W Contrast IV:Find:Pt:Upper extremity.left>Finger.fourth:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Pituitary+Sella turcica:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Temporal bone.bilateral:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Temporal bone.bilateral:Doc:CT


name: Guidance for localization of tumor^W 18F-FDG IV:Find:Pt:Head+Neck:Doc:PT+CT


name: Multisection^W contrast IV:Find:Pt:Head>Maxillofacial region.right:Doc:CT


name: Multisection for amyloidosis^W radionuclide IV:Find:Pt:Head>Brain:Doc:PT+CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Maxillofacial region:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Head>Temporomandibular joint:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head & Head>Sinuses:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head & Head>Maxillofacial region:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Pelvis>Pelvis bones:Doc:CT


name: Guidance for localization of tumor^W 18F-FDG IV+W Contrast IV:Find:Pt:Whole body>Skull vertex to mid-thigh:Doc:PT+CT


name: Guidance for injection of cyst:Find:Pt:XXX:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Parathyroid gland:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Pelvis>Pelvis bones:Doc:CT


name: Multisection^W contrast IT:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:CT


name: Bacteria identified:Prid:Pt:Amnio fld:Nom:Aerobic culture


name: Bacteria identified:Prid:Pt:Implanted device:Nom:Aerobic culture


name: Bacteria identified:Prid:Pt:Amnio fld:Nom:Anaerobic culture


name: Bacteria identified:Prid:Pt:Bil fld:Nom:Anaerobic culture


name: Bacteria identified:Prid:Pt:Implanted device:Nom:Anaerobic culture


name: Bacteria identified:Prid:Pt:Pericard fld:Nom:Anaerobic culture


name: Bacteria identified:Prid:Pt:Periton fld:Nom:Anaerobic culture


name: Chlamydia trachomatis:PrThr:Pt:Tiss:Ord:Organism specific culture


name: Escherichia coli eaeA gene:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Helicobacter pylori:PrThr:Pt:Stool:Ord:Organism specific culture


name: Helicobacter pylori:PrThr:Pt:Tiss:Ord:Organism specific culture


name: Legionella sp identified:Prid:Pt:Tiss:Nom:Organism specific culture


name: Legionella sp identified:Prid:Pt:Water:Nom:Organism specific culture


name: Neisseria meningitidis:PrThr:Pt:Thrt:Ord:Organism specific culture


name: Varicella zoster virus DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Microscopic observation:Prid:Pt:Bone mar:Nom:Giemsa stain


name: Microscopic observation:Prid:Pt:Bone mar:Nom:Gram stain


name: Microscopic observation:Prid:Pt:Body fld:Nom:Giemsa stain


name: Microscopic observation:Prid:Pt:Amnio fld:Nom:Giemsa stain


name: Microscopic observation:Prid:Pt:Amnio fld:Nom:Gram stain


name: Fungus identified:Prid:Pt:Dial fld prt:Nom:Culture


name: Toxoplasma gondii:PrThr:Pt:Bone mar:Ord:Organism specific culture


name: Leishmania sp identified:Prid:Pt:Bone mar:Nom:Organism specific culture


name: Leishmania sp identified:Prid:Pt:Bld:Nom:Organism specific culture


name: Acanthamoeba sp DNA:PrThr:Pt:Contact lens:Ord:Probe.amp.tar


name: Toxoplasma gondii DNA:PrThr:Pt:Bone mar:Ord:Probe.amp.tar


name: Acanthamoeba sp identified:Prid:Pt:CSF:Nom:Organism specific culture


name: Acanthamoeba sp identified:Prid:Pt:Contact lens:Nom:Organism specific culture


name: Strongyloides sp identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Fasciola hepatica Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Microscopic observation:Prid:Pt:Contact lens:Nom:Gram stain


name: Microscopic observation:Prid:Pt:Plr fld:Nom:Giemsa stain


name: Microscopic observation:Prid:Pt:Dial fld prt:Nom:Gram stain


name: Kanamycin 2.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency:Likelihood:Pt:^Fetus:Qn


name: Objective assessment of cardiovascular disease:Class:Pt:^Patient:Ord:NYHA


name: How often have you had five or more drinks in one D during the past Y:NRat:1Y:^Patient:Qn:Reported


name: How often have you had five or more drinks in one D during the past Y


name: P super little k Ab:PrThr:Pt:Ser/Plas:Ord


name: P super little k Ab:PrThr:Pt:Ser/Plas^BPU:Ord


name: P super little k Ab:PrThr:Pt:Ser/Plas^Donor:Ord


name: P super little k Ag:PrThr:Pt:RBC^BPU:Ord


name: P super little k Ag:PrThr:Pt:RBC^Donor:Ord


name: Cells.CD4-CD8-CD45R+TCR alpha beta+/100 cells.CD3:NFr:Pt:Bld:Qn:Flow cytometry


name: Cells.CD4-CD8-CD45R+TCR alpha beta+/100 cells.CD3


name: Cells.CD4-CD8-CD45R+TCR alpha beta+:NCnc:Pt:Bld:Qn:Flow cytometry


name: Aquaporin 4 water channel Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Porcine epidemic diarrhea virus S1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Person completing form title:Type:Pt:Provider:Nom


name: Initial case report processing information:Find:Pt:Report:Doc


name: Reportable condition response description.brief:Find:Pt:^Patient:Nar


name: Reportable condition response description.brief


name: Reportable condition response information and summary:Find:Pt:^Patient:Doc


name: Reportable condition response information and summary


name: Reportability response report:Find:Pt:{Setting}:Doc:Public health


name: Age range for infant less than 1Mo old:Find:Pt:^Patient:Nom


name: Estimated body mass index greater than 40:Find:Pt:^Patient:Ord


name: Known bacterial drug resistant infection:Find:Pt:^Patient:Ord


name: First degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: First degree burn area/Body surface area


name: Second degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Second degree burn area/Body surface area


name: Third degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Third degree burn area/Body surface area


name: Fourth degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Fourth degree burn area/Body surface area


name: Cardiopulmonary resuscitation stop time:ClockTime:Pt:^Patient:Qn


name: Cardiopulmonary resuscitation was being given on arrival at destination:Find:Pt:^Patient:Ord


name: Symptoms present for at least 24H:Find:Pt:^Patient:Ord:Reported


name: Gentamicin^random post extended interval dosing:SCnc:Pt:Ser/Plas:Qn


name: Aspartate aminotransferase:CCnc:Pt:Ser/Plas:Qn:No addition of P-5'-P


name: Escherichia coli gene panel:-:Pt:XXX:-:Probe.amp.tar


name: Within the past 12Mo we worried whether our food would run out before we got money to buy more:Find:Pt:^Patient:Ord:U.S. Food Security Survey


name: Within the past 12Mo the food we bought just didn't last and we didn't have money to get more:Find:Pt:^Patient:Ord:U.S. Food Security Survey


name: Escherichia coli enterotoxigenic gene panel:-:Pt:XXX:-:Probe.amp.tar


name: Escherichia coli enterotoxigenic gene panel


name: Herpes simplex virus identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Herpes simplex virus 1 DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Herpes simplex virus 2 DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Varicella zoster virus:PrThr:Pt:Cornea/Conjunctiva:Ord:Organism specific culture


name: Varicella zoster virus:PrThr:Pt:Ocular fld:Ord:Organism specific culture


name: Herpes simplex virus DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Bacteria identified:Prid:Pt:Ocular fld:Nom:Anaerobic culture


name: Tropheryma whipplei DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Bacteria identified:Prid:Pt:Ocular fld:Nom:Aerobic culture


name: Microscopic observation:Prid:Pt:Periton fld:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Pericard fld:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Pericard fld:Nom:Gram stain


name: Microscopic observation:Prid:Pt:Genital:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Ocular fld:Nom:Giemsa stain


name: Microscopic observation:Prid:Pt:Wound:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Cvx:Nom:Acid fast stain.Kinyoun


name: Microscopic observation:Prid:Pt:Bone mar:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Sinus:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Ocular fld:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Amnio fld:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Semen:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Ocular fld:Nom:Gram stain


name: Microscopic observation:Prid:Pt:Asp:Nom:Acid fast stain


name: Toxoplasma gondii:PrThr:Pt:Ocular fld:Ord:Organism specific culture


name: Acanthamoeba sp identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Toxoplasma gondii DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Mycobacterium tuberculosis DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Mycobacterium sp identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Mycobacterium sp identified:Prid:Pt:Ocular fld:Nom:Organism specific culture


name: Deprecated Microscopic observation [Presence] in Vomitus by Acid fast stain


name: Microscopic observation:PrThr:Pt:Cornea/Conjunctiva:Ord:Acid fast stain


name: Microscopic observation:PrThr:Pt:Isolate:Ord:Acid fast stain


name: Microscopic observation:PrThr:Pt:Plr fld:Ord:Acid fast stain


name: Wuchereria bancrofti+Brugia malayi Ab.IgG4:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG3:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG2:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG1:PrThr:Pt:Ser:Ord:IA


name: Ebola & Marburg virus RNA panel:-:Pt:Bld:-:Probe.amp.tar


name: Influenza virus A subtype:Prid:Pt:Cornea/Conjunctiva:Nom:Probe.amp.tar


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: Crimean-Congo hemorrhagic fever virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Crimean-Congo hemorrhagic fever virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Crimean-Congo hemorrhagic fever virus RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Influenza virus B Ag:PrThr:Pt:Tiss:Ord:IF


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Influenza virus identified:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Herpes simplex virus 1 Ag:PrThr:Pt:Tiss:Ord:IF


name: Respiratory syncytial virus B RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Dengue virus 1 & 2 & 3 & 4 RNA:Prid:Pt:Ser/Bld:Nom:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Lymphocytic choriomeningitis virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Lymphocytic choriomeningitis virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus 2 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: HIV 1 proviral DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Parechovirus RNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Probe.amp.tar


name: Microscopic observation:Prid:Pt:Bil fld:Nom:Acid fast stain


name: Microscopic observation:PrThr:Pt:Synv fld:Ord:Acid fast stain


name: Microscopic observation:Prid:Pt:Synv fld:Nom:Giemsa stain


name: LCDS v4.00 - Functional abilities and goals - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Functional abilities and goals - planned discharge


name: LCDS v4.00 - Functional abilities and goals:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Functional abilities and goals


name: Guidance for infusion of non-thrombolytic:Find:Pt:Head>Head arteries:Doc:{Imaging modality}


name: Guidance for removal of tunneled catheter:Find:Pt:Chest>Pleura:Doc:{Imaging modality}


name: Guidance for removal of tunneled catheter


name: Acinetobacter sp (rpsA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaIMP gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaNDM gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaOXA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaVIM gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial cephalosporin resistance blaCTX-M gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial methicillin resistance mecA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial vancomycin resistance vanA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial vancomycin resistance vanB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Citrobacter sp (ompA+mrkC) genes:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterobacter sp (gyrB+metB) genes:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterococcus faecalis hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterococcus faecium hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Gram positive bacteria identified:Imp:Pt:Bld.pos growth:Nom:Probe


name: Gram positive blood culture panel:-:Pt:Bld.pos growth:-:Probe


name: Klebsiella oxytoca (ompA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Klebsiella pneumoniae yggE gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Listeria sp (tuf) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Mycobacterium sp rRNA:Prid:Pt:Bld.pos growth:Nom:Probe


name: Proteus sp (atpD) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Pseudomonas aeruginosa (sodA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus aureus gyrB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus epidermidis hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus lugdunensis sodA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus sp tuf gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus agalactiae hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus anginosus group gyrB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus pneumoniae gryB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus pyogenes hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus sp tuf gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Multisection^WO contrast & Multisection for left ventricular function


name: WO contrast and for left ventricular function W contrast IV


name: Escherichia coli enterotoxigenic heat-labile toxin


name: Inpatient discharge facility within the past 14D


name: Reportable condition response information


name: Observation unit (unit that provides < 24 hour stays)


name: Telemetry/step-down unit (less acuity than ICU)


name: Other (jail, institutional care, mental health, etc.)


name: Supportive care with no Renal Replacement Therapy (RRT)


name: Indwelling catheter (including suprapubic catheter and nephrostomy tube)


name: Ostomy (including urostomy, ileostomy, and colostomy)


name: Formal assessment instrument/tool (e.g., Braden, Norton, or other)


name: Central venous catheter lumen obstruction


name: Catheter portion only of central venous catheter with port


name: Tunneled central venous catheter without port


name: Non-tunneled central venous catheter without port


name: arginine/glutamine/calcium HMB/collagen/multivitamin-mineral 7 gram-7 gram-1.5 gram-2.5 gram ORAL POWDER IN PACKET (EA)


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTISALATE 4 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL CREAM [Olay Total Effects Whip Active Moisturizer Broad Spectrum SPF 25 Sunscreen]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Hailey Fe 1/20 28 Day]


name: FAMCICLOVIR 1 g in 1 g NOT APPLICABLE POWDER


name: Kaolin 45.5 g in 130 g TOPICAL CREAM [SONATURAL THE PURE PORE TENSING CARBONIC BUBBLE POP CLAY MASK]


name: MITOMYCIN 24.75 g in 25 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: {1 (10 ML) (polyethylene glycol 400 0.004 MG/MG / propylene glycol 0.003 MG/MG Ophthalmic Gel) / 1 (10 ML) (polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Solution) } Pack


name: GNP Cold Max Day/Night Cool Taste Caplet


name: Diclofenac Sodium;Folic Acid/Methylcobalamin/Pyridoxine 3%; 400 MCG-1100 MCG-46 MG Multiple Routes Kit [ORMECA THERAPY]


name: Clever Choice Anti-Static Valved Holding Chamber with Mask (Large)


name: Clever Choice Anti-Static Valved Holding Chamber with Mask (Medium)


name: Clever Choice Anti-Static Valved Holding Chamber with Mask (Small)


name: Clever Choice Comfort EZ 32G 5/16 inch Short Pen Needle


name: Clever Choice Comfort EZ 33G 1/4 inch Pen Needle


name: Clever Choice Comfort EZ 33G 3/16 inch Mini Pen Needle


name: Clever Choice Comfort EZ 33G 5/16 inch Short Pen Needle


name: Clever Choice Comfort EZ Pressure Activated Safety Lancet 21G (Green)


name: Clever Choice Comfort EZ Pressure Activated Safety Lancet 23G (Yellow)


name: Clever Choice Comfort EZ Pressure Activated Safety Lancet 28G (Purple)


name: Clever Choice Whisper Aire Pediatric Compressor Nebulizer System


name: HOMOSALATE 5 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 1 g in 100 mL / OXYBENZONE 6 g in 100 mL TOPICAL LOTION [CORETEX SUN X SPF 30]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 73 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [Milani Prime Protect SPF 30 Face Primer]


name: OCTOCRYLENE 2.5 g in 100 mL / HOMOSALATE 7.5 g in 100 mL / OXYBENZONE 6 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LIPSTICK [SUN XSPF 30 BROAD SPECTRUM SUNSCREEN LIP BALM]


name: ZINC OXIDE 19.8 g in 165 g TOPICAL DRESSING [McKesson Unna Boot 3]


name: ZINC OXIDE 24.6 g in 205 g TOPICAL DRESSING [McKesson Unna Boot 4]


name: ZINC OXIDE 4.95 g in 165 g / FERRIC OXIDE RED 0.35 g in 165 g TOPICAL DRESSING [McKesson Unna Boot with Calamine 3]


name: ZINC OXIDE 6.15 g in 205 g / FERRIC OXIDE RED 0.43 g in 205 g TOPICAL DRESSING [McKesson Unna Boot with Calamine 4]


name: SILICON DIOXIDE 0.88 g in 11 g TOPICAL STICK [SONATURAL ALL KILL BLACKHEAD CLEAR]


name: OCTINOXATE 7.5 mg in 1 g / OXYBENZONE 5.0 mg in 1 g / PETROLATUM 30.0 mg in 1 g / OCTOCRYLENE 7.0 mg in 1 g / OCTISALATE 5.0 mg in 1 g TOPICAL STICK [Sunfrog Ultra SPF 30 Lip Balm]


name: TITANIUM DIOXIDE 0.1462 g in 1 g / OCTINOXATE 0.067 g in 1 g / OCTISALATE 0.04 g in 1 g TOPICAL CREAM [Lagom CF Cushion 10]


name: ZINC OXIDE 128.8 mg in 1 mL / TITANIUM DIOXIDE 33.7 mg in 1 mL Topical CREAM [No Makeup Foundation Fair Broad Spectrum SPF 30]


name: METHAZOLAMIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 59.8 mg in 1 g / TITANIUM DIOXIDE 48.0 mg in 1 g TOPICAL CREAM [No Makeup Concealer Fair Broad Spectrum SPF 35]


name: ZINC OXIDE 128.8 mg in 1 mL / TITANIUM DIOXIDE 33.7 mg in 1 mL Topical CREAM [No Makeup Foundation Fair-Light Broad Spectrum SPF 30]


name: BENZETHONIUM CHLORIDE 0.2 mg in 10 mL / DYCLONINE HYDROCHLORIDE 0.75 mg in 10 mL TOPICAL LIQUID [Benzethonium chloride Plus Dyclonine hydrochloride]


name: OCTINOXATE 0.07 g in 1 g / ZINC OXIDE 0.084 g in 1 g TOPICAL CREAM [CY BB Facial Hidratante con Color FPS 25 Multibeneficios]


name: MEPIVACAINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: FreeStyle Libre 10-d Reader Glucose Monitorin


name: FreeStyle Libre 10-d Sensor Glucose Monitorin


name: feeder container with gravity set, ENFit MISCELL EACH


name: syringe,safety with needle,1 mL 27 gauge X 5/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: gel-matrix pad dressing, silicone 2" X 5.5" TOPICAL PAD


name: Northside Hospital H.E.A.R.T. Strings Bag KIT


name: TITANIUM DIOXIDE 0.1462 g in 1 g / OCTINOXATE 0.067 g in 1 g / OCTISALATE 0.04 g in 1 g TOPICAL CREAM [Lagom CF Cushion 20]


name: ZINC OXIDE 86 mg in 1 g / TITANIUM DIOXIDE 65 mg in 1 g TOPICAL CREAM [Sun Armor SPF 50]


name: nutritional therapy for phenylketonuria (PKU) no.69 19 gram-390 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [SheerZinc SPF 30 Tinted - Nude]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 20 g in 100 g TOPICAL CREAM [Gillette Clinical Soft Ultimate Fresh]


name: ZINC OXIDE 170 mg in 1 g TOPICAL CREAM [Light Tint Clear Zinc Solar Protection SPF 30]


name: ZINC OXIDE 176.7 mg in 1 g TOPICAL CREAM [Tinted Clear Zinc Solar Protection SPF 30]


name: METAMIZOLE SODIUM .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: BENZETHONIUM CHLORIDE 0.2 mg in 9 mL / DYCLONINE HYDROCHLORIDE 0.75 mg in 9 mL TOPICAL LIQUID [Benzethonium chloride Plus Dyclonine hydrochloride]


name: DECOQUINATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: IBUTAMOREN MESYLATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Broad Spectrum SPF 30 for Face and Body]


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Povidone Iodine 10 MG/1 ML; 70%; 10% Multiple Routes Kit [MAS CARE-PAK]


name: ZINC OXIDE 85.0 mg in 1 mL / TITANIUM DIOXIDE 65.0 mg in 1 mL TOPICAL CREAM [Cover Recover SPF 30 Beige]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Pyratine XR Creme With Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 85.0 mg in 1 mL / TITANIUM DIOXIDE 65.0 mg in 1 mL TOPICAL CREAM [Cover Recover SPF 30 Cocoa]


name: LEVOMENOL 0.07 g in 15 mL TOPICAL OIL [PurpleU BAOBAB FACE]


name: Kaolin 4.0 g in 100 g TOPICAL CREAM [Dr Pore Tightening PINK CLAY FACIAL MASK]


name: Kaolin 8.0 g in 100 mL TOPICAL CREAM [Dr Pore Tightening GLACIAL CLAY FACIAL MASK]


name: altrenogest 247.5 g in 250 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ENROFLOXACIN 19.8 kg in 20 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 50.0 mg in 1 mL / TITANIUM DIOXIDE 48.0 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Moisturizer Broad Spectrum SPF 20]


name: ZINC OXIDE 50.0 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 51.4 mg in 1 mL / TITANIUM DIOXIDE 73.6 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Broad Spectrum SPF 45]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Clear Daylight Radiance Moisturizer Broad Spectrum SPF 32]


name: MIRTAZAPINE HEMIHYDRATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: OCTINOXATE 6 g in 100 mL / ZINC OXIDE 3 g in 100 mL TOPICAL LOTION [Olay Age Defying Classic Daily Renewal Broad Spectrum SPF 15]


name: TIOPRONIN 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Isocitrate Dehydrogenase 2 Inhibitor [EPC]


name: ZINC OXIDE 55 mg in 1 mL / TITANIUM DIOXIDE 44 mg in 1 mL TOPICAL CREAM [Mineral Foundation SPF 30-3W]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Light Daylight Tinted Radiance Moisturizer Broad Spectrum SPF 32]


name: SUNFLOWER OIL 7.92 g in 14 g TOPICAL STICK [OrgaPlus Super Care Balm for combination and oi ly skin type 14g]


name: SUNFLOWER OIL 11.31 g in 20 g TOPICAL STICK [OrgaPlus Super Care Balm for combination and oi ly skin type 20g]


name: ERBORIAN DOUBLE SAMPLE CC CREME CLAIR and DORE SPF 25 KIT


name: TeroDerm-Plus Cream Base for Compounding


name: TITANIUM DIOXIDE 0.65 g in 1 g TOPICAL EMULSION [Oi Lin Natural Emulsion SPF 30]


name: nutritional therapy phenylketonuria (PKU) no.69


name: Octinoxate 75 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octocrylene 27.9 mg in 1 mL TOPICAL STICK [Nu Skin Sunright Lip Balm Broad Spectrum SPF 15]


name: TACROLIMUS 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: diluent for rasburicase (poloxamer 188) INTRAVEN AMPUL (ML)


name: PYRAZINAMIDE 11.88 kg in 12 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PIROXICAM 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: BUTAFOSFAN 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: CARBIMAZOLE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: HYDROQUINONE 19 mg in 1 g TOPICAL CREAM [SYMBA Skin Lightening]


name: ZINC OXIDE 60 mg in 1 g / TITANIUM DIOXIDE 47 mg in 1 g TOPICAL CREAM [Quench and Protect Hydrating SPF 30]


name: ZINC OXIDE 63 mg in 1 mL / TITANIUM DIOXIDE 23.6 mg in 1 mL TOPICAL LOTION [Youth 1 Activating BB Cream SPF 30 Light]


name: ZINC OXIDE 86 mg in 1 mL / TITANIUM DIOXIDE 65 mg in 1 mL TOPICAL CREAM [Sun Shield SPF 50]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 45 mg in 1 mL TOPICAL CREAM [EMINENCE Red Currant Protective Moisturizer]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL CREAM [Bio Active Complex SPF 15]


name: ZINC OXIDE 177 mg in 1 mL TOPICAL CREAM [Everyday Sheer Coverage Light Tint SPF 20]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Tropical Topical Matte SPF 30]


name: ZINC OXIDE 189 mg in 1 mL TOPICAL CREAM [Natural Protection Face and Eyes SPF 30]


name: ZINC OXIDE 21 g in 100 mL TOPICAL CREAM [Shield]


name: AVOBENZONE 15 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / ECAMSULE 5 mg in 1 mL / TITANIUM DIOXIDE 25 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 30 Sport Water Resistant]


name: AVOBENZONE 15 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / ECAMSULE 5 mg in 1 mL / TITANIUM DIOXIDE 33 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 45 Sport]


name: AVOBENZONE 22.4 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 24 mg in 1 mL / OCTOCRYLENE 44.8 mg in 1 mL / OXYBENZONE 28.8 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 30 Sport Endurance Water Resistant]


name: chlorhexidine / climbazole / salicyloyl phytosphingosine


name: SODIUM CITRATE 0.76 g in 29 mL / DEXTROSE MONOHYDRATE 0.74 g in 29 mL / CITRIC ACID MONOHYDRATE 94.8 mg in 29 mL / SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE 72.8 mg in 29 mL INTRAVENOUS INJECTION, SOLUTION [Sterile Cord Blood Collection Unit (MSC128D)]


name: Beta-1 adrenergic receptor antagonist (disposition)


name: Anterior pituitary hormone (disposition)


name: massage soft/superficial tissue by active release technique


name: proprioceptive neuromuscular facilitation of shoulder


name: proprioceptive neuromuscular facilitation of elbow


name: proprioceptive neuromuscular facilitation of elbow to increase ROM


name: proprioceptive neuromuscular facilitation of elbow to increase strength


name: proprioceptive neuromuscular facilitation of forearm


name: proprioceptive neuromuscular facilitation of forearm to increase ROM


name: proprioceptive neuromuscular facilitation of forearm to increase strength


name: proprioceptive neuromuscular facilitation of wrist


name: proprioceptive neuromuscular facilitation of wrist to increase ROM


name: proprioceptive neuromuscular facilitation of wrist to increase strength


name: proprioceptive neuromuscular facilitation of hand


name: proprioceptive neuromuscular facilitation of fingers to increase ROM


name: proprioceptive neuromuscular facilitation of fingers to increase strength


name: proprioceptive neuromuscular facilitation of fingers


name: proprioceptive neuromuscular facilitation to increase ROM of right fingers


name: proprioceptive neuromuscular facilitation to increase ROM of left fingers


name: proprioceptive neuromuscular facilitation to increase ROM of fingers of both hands


name: proprioceptive neuromuscular facilitation to increase strength of right fingers


name: proprioceptive neuromuscular facilitation to increase strength of left fingers


name: proprioceptive neuromuscular facilitation to increase strength of fingers of both hands


name: high daily dosage of glucocorticoid therapy


name: high daily dosage of glucocorticoid therapy for longer than six months with no change in disease activity


name: high daily dosage of glucocorticoid therapy for longer than six months with improvement in disease activity


name: high daily dosage of glucocorticoid therapy for longer than six months


name: physician to call insurance provider for authorization


name: prophylactic removal of fallopian tube(s)


name: proprioceptive neuromuscular facilitation of hip


name: proprioceptive neuromuscular facilitation of hip to increase ROM


name: proprioceptive neuromuscular facilitation of hip to increase strength


name: proprioceptive neuromuscular facilitation of knee


name: proprioceptive neuromuscular facilitation of knee to increase ROM


name: proprioceptive neuromuscular facilitation of knee to increase strength


name: proprioceptive neuromuscular facilitation of lower leg


name: proprioceptive neuromuscular facilitation of lower leg to increase ROM


name: proprioceptive neuromuscular facilitation of lower leg to increase strength


name: proprioceptive neuromuscular facilitation of ankle


name: proprioceptive neuromuscular facilitation of ankle to increase ROM


name: proprioceptive neuromuscular facilitation of ankle to increase strength


name: proprioceptive neuromuscular facilitation of toes


name: proprioceptive neuromuscular facilitation of toes to increase ROM


name: proprioceptive neuromuscular facilitation of toes to increase strength


name: swallowing dysfunction treatment: hold baby upright after feeding


name: test results documented and reviewed for biopsy


name: test results reported to primary care or referring physician


name: chiropractic adjustment of cervical spine


name: chiropractic adjustment of thoracic spine


name: chiropractic adjustment sacroiliac joint


name: chiropractic technique: advanced biostructural correction


name: chiropractic adjustment sacroiliac joint left


name: chiropractic adjustment sacroiliac joint right


name: chiropractic adjustment of upper extremity


name: chiropractic adjustment of lower extremity


name: chiropractic technique: atlas orthogonal


name: chiropractic technique: applied kinesiology


name: chiropractic technique: flexion distraction


name: chiropractic technique: Korean Specific Technique


name: low daily dosage of glucocorticoid therapy


name: chiropractic technique: sacro-occipital technique


name: advance care planning discussion documented with advance care plan documented


name: closed treatment of shoulder dislocation using leveraging technique


name: closed treatment of shoulder dislocation using traction technique


name: assessment of and care planning for cognitive impairment, 60 minutes


name: psychiatric collaborative care management


name: psychiatric collaborative care management, initial 70 minutes


name: psychiatric collaborative care management, subsequent 60 minutes


name: psychiatric collaborative care management, each additional 30 minutes


name: behavioral health integration care management


name: anesthesia for upper endoscopy with endoscope introduced proximal to duodenum


name: anesthesia for lower endoscopy with endoscope introduced distal to duodenum


name: anesthesia for screening colonoscopy with endoscope introduced distal to duodenum


name: anesthesia for combined upper and lower endoscopy


name: anesthesia for upper and lower endoscopy with endoscope introduced proximal and distal to duodenum


name: surgical flap with preservation of vascular pedicle


name: midface flap with preservation of vascular pedicle


name: preparation of breast tumor cavity with placement of radiotherapy applicator


name: preparation of breast tumor cavity with placement of radiotherapy applicator for intraoperative radiation therapy during partial mastectomy


name: orthopedic surgery bone grafting proximal femur


name: bone marrow aspiration for spinal bone graft


name: nasal endoscopy with ligation of sphenopalatine artery


name: nasal endoscopy with total ethmoidectomy with frontal sinus exploration and tissue removal


name: nasal endoscopy with total ethmoidectomy with sphenoidotomy


name: nasal endoscopy with total ethmoidectomy with sphenoidotomy and removal of sphenoid sinus tissue


name: nasal endoscopy with dilation of frontal and sphenoid sinus ostia


name: removal of total replacement heart system


name: treatment plan reported to primary care or referring physician


name: endovascular repair of infrarenal aorta using aorto-aortic tube endograft


name: endovascular repair of infrarenal aorta using aorto-aortic tube endograft for rupture


name: endovascular repair of infrarenal aorta using aorto-uni-iliac endograft


name: endovascular repair of infrarenal aorta using aorto-un-iliac endograft for rupture


name: endovascular repair of infrarenal aorta using aorto-bi-iliac endograft


name: endovascular repair of infrarenal aorta using aorto-bi-iliac endograft for rupture


name: endovascular repair of iliac artery using ilio-iliac tube endograft


name: endovascular repair of iliac artery using ilio-iliac tube endograft for rupture


name: endovascular repair of iliac artery using aorto-un-iliac endograft


name: endovascular repair of iliac artery using aorto-un-iliac endograft for rupture


name: endovascular repair of iliac artery using aorto-bi-iliac endograft


name: endovascular repair of iliac artery using aorto-bi-iliac endograft for rupture


name: endovascular repair of infrarenal aorta with placement of extension prosthesis


name: endovascular repair of infrarenal aorta with placement of extension prosthesis distal to common iliac artery


name: endovascular repair of infrarenal aorta with placement of extension prosthesis proximal to renal artery


name: endovascular repair of iliac artery with placement of extension prosthesis


name: endovascular repair of iliac artery with placement of extension prosthesis distal to common iliac artery


name: endovascular repair of iliac artery with placement of extension prosthesis proximal to renal artery


name: endovascular repair of infrarenal aorta with delayed placement of extension prosthesis


name: endovascular repair of infrarenal aorta with delayed placement of extension prosthesis, initial vessel


name: endovascular repair of infrarenal aorta with delayed placement of extension prosthesis, each additional vessel


name: endovascular repair of iliac artery with delayed placement of extension prosthesis


name: endovascular repair of iliac artery with delayed placement of extension prosthesis, initial vessel


name: endovascular repair of iliac artery with delayed placement of extension prosthesis, each additional vessel


name: transcatheter delivery of enhanced fixation device to endograft


name: percutaneous femoral artery access and closure for endograft delivery


name: unilateral percutaneous femoral artery access and closure for endograft delivery


name: open femoral artery exposure with creation of conduit for delivery of endovascular prosthesis


name: open femoral artery exposure with creation of conduit for cardiopulmonary bypass


name: open iliac artery exposure with creation of conduit for cardiopulmonary bypass


name: outreach and engagement in treatment directed by health care professional


name: assessment & intervention initial assessment


name: initial assessment with administration of rating scales


name: initial assessment with development of treatment plan


name: subsequent monitoring of outcomes using rating scales


name: psychiatric review of plan, including modifications


name: psychiatric subsequent progress review & recommendations for changes


name: psychiatric subsequent progress review & recommendations for changes in meds


name: coordination of care - entry of patient in registry


name: tracking of patient follow-up and progress using registry with documentation


name: track patient follow-up & progress using registry w/ document initial


name: track patient follow-up & progress using registry w/ document subsequent


name: coordination of care - caseload consultation


name: coordination of care - caseload consultation, initial


name: coordination of care - caseload consultation, subsequent


name: intervention using evidence-based techniques


name: intervention using behavioral activation


name: intervention using motivational interviewing


name: intervention using focused treatment strategies


name: collaborate & coordinate mental health care w/ health care professional


name: coordination of care - relapse prevention planning


name: behavioral health care planning with revision of plan


name: coordination of care - facilitation and coordination of treatment


name: facilitation and coordination of treatment counseling


name: facilitation and coordination of treatment pharmacotherapy


name: facilitation and coordination of treatment psychiatric consultation


name: facilitation and coordination of treatment psychotherapy


name: open axillary/subclavian artery exposure


name: open axillary/subclavian artery exposure for delivery of endovascular prosthesis


name: open axillary/subclavian artery exposure with creation of conduit for delivery of endovascular prosthesis


name: open axillary/subclavian artery exposure with creation of conduit for cardiopulmonary bypass


name: venous sclerosing injection of non-compounded foam w/ ultrasound compression


name: venous sclerosing by injection of non-compounded foam with ultrasound compression maneuvers, single vein


name: venous sclerosing by injection of non-compounded foam with ultrasound compression maneuvers, multiple veins, same leg


name: endovenous ablation of incompetent vein by transcatheter delivery of chemical adhesive


name: endovenous ablation of initial incompetent vein by transcatheter delivery of chemical adhesive, initial vein


name: endovenous ablation of additional incompetent vein by transcatheter delivery of chemical adhesive, each additional vein


name: laparoscopy, bilateral total pelvic lymphadenectomy, peri-aortic lymph node sampling, washings, biopsies, omentectomy


name: PTA of posterior tibial artery, initial vessel


name: PTA of posterior tibial artery, initial vessel, with atherectomy


name: PTA of posterior tibial artery, initial vessel, with stent


name: PTA of posterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of posterior tibial artery, additional vessel


name: PTA of posterior tibial artery, additional vessel, with atherectomy


name: PTA of posterior tibial artery, additional vessel, with stent


name: PTA of posterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of posterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of posterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of right posterior tibial artery, initial vessel


name: PTA of right posterior tibial artery, initial vessel, with atherectomy


name: PTA of right posterior tibial artery, initial vessel, with stent


name: PTA of right posterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of right posterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of right posterior tibial artery, additional vessel


name: PTA of right posterior tibial artery, additional vessel, with atherectomy


name: PTA of right posterior tibial artery, additional vessel, with stent


name: PTA of right posterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of right posterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of right posterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right posterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of posterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of posterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left posterior tibial artery, initial vessel


name: PTA of left posterior tibial artery, initial vessel, with atherectomy


name: PTA of left posterior tibial artery, initial vessel, with stent


name: PTA of left posterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of left posterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of left posterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left posterior tibial artery, additional vessel


name: PTA of left posterior tibial artery, additional vessel, with atherectomy


name: PTA of left posterior tibial artery, additional vessel, with stent


name: PTA of left posterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of left posterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of left posterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right anterior tibial artery, initial vessel


name: PTA of right anterior tibial artery, initial vessel, with atherectomy


name: PTA of right anterior tibial artery, initial vessel, with stent


name: PTA of right anterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of right anterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of right anterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right anterior tibial artery, additional vessel


name: PTA of right anterior tibial artery, additional vessel, with atherectomy


name: PTA of right anterior tibial artery, additional vessel, with stent


name: PTA of right anterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of right anterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of right anterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left anterior tibial artery, initial vessel


name: PTA of left anterior tibial artery, initial vessel, with atherectomy


name: PTA of left anterior tibial artery, initial vessel, with stent


name: PTA of left anterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of left anterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of left anterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left anterior tibial artery, additional vessel


name: PTA of left anterior tibial artery, additional vessel, with atherectomy


name: PTA of left anterior tibial artery, additional vessel, with stent


name: PTA of left anterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of left anterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of left anterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of anterior tibial artery, initial vessel


name: PTA of anterior tibial artery, initial vessel, with atherectomy


name: PTA of anterior tibial artery, initial vessel, with stent


name: PTA of anterior tibial artery, initial vessel, with drug-eluting stent


name: PTA of anterior tibial artery, initial vessel, with atherectomy and stent


name: PTA of anterior tibial artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of anterior tibial artery, additional vessel


name: PTA of anterior tibial artery, additional vessel, with atherectomy


name: PTA of anterior tibial artery, additional vessel, with stent


name: PTA of anterior tibial artery, additional vessel, with drug-eluting stent


name: PTA of anterior tibial artery, additional vessel, with atherectomy and stent


name: PTA of anterior tibial artery, additional vessel, with atherectomy and drug-eluting stent


name: laparoscopy with total hysterectomy for malignancy


name: laparoscopy with total hysterectomy for malignancy with omentectomy and salpingo-oophorectomy


name: neurorrhaphy with nerve allograft, initial strand


name: neurorrhaphy with nerve allograft, additional strand


name: referral to tobacco use cessation services


name: amputation of both lower limbs (except toes alone)


name: urine culture for Enterobacteriaceae Serratia


name: urine culture for Enterobacteriaceae Serratia marcescens


name: urine culture for Pseudomonas aeruginosa


name: urine culture for Staphylococcus saprophyticus


name: behavior rating inventory of executive function 2 (BRIEF-2)


name: Behavior Assessment System for Children, 3rd edition (BASC-3)


name: BASC-3 attention problems clinical scale


name: BASC-3 activities of daily living adaptive scale


name: BASC-3 study functional communication adaptive scale


name: BASC-3 externalizing problems composite score


name: BASC-3 internalizing problems composite score


name: BASC-3: self report of clinical and adaptive scales


name: BASC-3 self report: attitude to teachers


name: BASC-3 self report: interpersonal relations


name: BASC-3 self report: relations with parents


name: BASC-3 self report: school maladjustment score


name: BASC-3: self report of personality content scale


name: NAA with probe detection for Trichomonas vaginalis DNA


name: NAA with probe detection for Trichomonas vaginalis DNA presence in vaginal fluid


name: NAA with probe detection for bacterial vaginosis DNA and score panel


name: NAA with probe detection for bacterial vaginosis DNA and score panel in vaginal fluid


name: viral Epstein-Barr IgM early antibody in serum


name: BRIEF-2 behavior regulation index (BRI) shift


name: BRIEF-2 behavior regulation index (BRI) emotional control


name: BRIEF-2 emotion regulation index (ERI) initiate


name: BRIEF-2 emotion regulation index (ERI) working memory


name: BRIEF-2 emotion regulation index (ERI) plan/organize


name: BRIEF-2 emotion regulation index (ERI) task-monitor


name: BRIEF-2 cognitive regulation index (CRI)


name: BRIEF-2 global executive composite (GEC)


name: BASC-3 developmental social disorders content scale


name: BASC-3 emotional self-control content scale


name: BASC-3 executive functioning content scale


name: BASC-3 negative emotionality content scale


name: BASC-3 overall executive functioning index


name: BASC-3 self report: inattention/hyperactivity


name: BASC-3 self report: internalizing problems


name: BASC-3 self report: composite score total


name: Ultrasonic guidance for needle placement


name: lower extremity functional scale questionnaire


name: peak expiratory flow post-bronchodilation


name: blood pH adjusted to patient's actual temperature


name: nasopharyngeal culture for Haemophilus influenzae


name: nasopharyngeal culture for Moraxella catarrhalis


name: nasopharyngeal culture for Streptococcus pneumoniae


name: oropharynx culture for Moraxella catarrhalis


name: arterial cord blood pH adjusted to patient's actual temperature


name: nonvascular ultrasound of complete joint of extremity


name: limited nonvascular ultrasound of joint or focal evaluation of other structure of extremity


name: genome sequence analysis panel for hereditary peripheral neuropathies


name: MAAA for oncology with microarray expression profiling of 70 content and 465 housekeeping genes


name: multianalyte assay with algorithmic analysis for oncology with mRNA expression profiling by real-time RT-PCR of 46 genes


name: multianalyte assays with algorithmic analyses for oncology with real-time PCR promoter methylation profiling of 3 genes


name: recombinant or purified allergen component specific IgE


name: Attention Deficit Disorders Evaluation Scale


name: pain level by West Haven-Yale multidimensional pain inventory


name: WHYMPI significant-other responses subscale


name: Angiotensin II receptor antagonist (disposition)


name: prescription drug monitoring in urine by definitive tandem mass spectrometry with chromatography


name: LVEF by 2D modified ultrasound, apical 2-chamber view and calculated by single plane method of disks


name: LVEF by 2D modified ultrasound, apical 4-chamber view and calculated by single plane method of disks


name: patient info entered in system, next exam date, follow-up process


name: substance use therapy - harm reduction program


name: hepatitis B e-antigen and e-antibody panel in serum


name: alpha lipoprotein entitic length in serum or plasma


name: skin lesion culture for herpes simplex type II


name: definitive chromatography with mass spectrometry of 120 or more urine analytes for interaction detection


name: saliva analysis rx drug monitor liquid chromatography w/ mass spectrometry


name: quantitative assessment of three urine metabolites by liquid chromatography with tandem mass spectrometry


name: nucleic acid amplified probe technique for respiratory syncytial virus


name: nucleic acid amplified probe technique for Zika virus


name: gene rearrangement analysis by whole genome next-generation sequencing


name: gene rearrangement analysis by whole genome next-generation sequencing, whole blood or bone marrow


name: gene rearrangement analysis by whole genome next-generation sequencing, whole blood


name: gene rearrangement analysis by whole genome next-generation sequencing, fresh or frozen tissue or cells


name: DNA PCR amplification and probe hybridization


name: DNA PCR amplification and probe hybridization of bacterial culture colonies


name: RBC antigen typing in whole blood, 35 antigens from 11 blood groups


name: Helicobacter pylori detection and antibiotic resistance analysis


name: Helicobacter pylori detection and antibiotic resistance analysis by next generation sequencing panel


name: molecular diagnostics erbb2 copy number variation identified by fish


name: ERBB2 copy number variation ID by FISH using dielectrophoresis sorting


name: whole genome sequencing for bacterial infectious disease typing


name: molecular diagnostics drug metabolism analysis by real-time pcr


name: drug metabolism analysis by real-time PCR 22 drug metabolism and transporter genes


name: PCR amplification for fusion transcript detection


name: PCR amplification for fusion transcript detection for BCR/ABL1


name: PCR amplification and sequence analysis of JAK2 exons 12-14


name: biochemical genetic studies serum proteins


name: biochemical genetic studies five serum proteins


name: multianalyte assays with algorithmic analyses for oncology with real-time RT-PCR mRNA expression analysis


name: gene expression profile by real-time PCR of 3 genes


name: gene expression profile by real-time PCR of 3 genes in urine


name: fecal analysis using noninvasive colorectal cancer DNA test with occult blood screening


name: fecal analysis using noninvasive colorectal cancer DNA test with occult blood screening, narrative interpretation


name: human papilloma virus in cervix, 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA interpretation


name: NAA with probe detection for human papilloma virus DNA


name: NAA with probe detection for human papilloma virus 16 DNA


name: NAA with probe detection for human papilloma virus 16 DNA in cervix


name: NAA with probe detection for human papilloma virus 18 DNA


name: NAA with probe detection for human papilloma virus 18 DNA in cervix


name: glucose monitor 72+ hrs continuous via subcutaneous sensor office-provided equip


name: glucose monitoring 72+ hours by continuous recording and subcutaneous sensor using patient-provided equipment


name: pulmonary stress testing for bronchospasm


name: retinal polarization scan for bilateral ocular screening


name: external patient-demand ECG event recorder, in-office connection


name: external patient-demand ECG event recorder, physician review and interpretation with patient-generated event


name: mcg multichannel fetal record, scan, & raw electronic signal transfer


name: mcg multichannel fetal signal extraction, analysis, and result


name: mcg multichannel fetal supervision, review, interpretation


name: mcg multichannel fetal review, interpretation, report


name: optical coherence tomography middle ear right


name: optical coherence tomography middle ear left


name: optical coherence tomography middle ear bilateral


name: optical coherence tomography skin initial lesion


name: optical coherence tomography skin additional lesion


name: CT angiography of coronary arteries with fractional flow reserve measurement


name: coronary CT angiography with fractional flow reserve measurement, data preparation and transmission


name: coronary CT angiography with fluid dynamics analysis, hyperemia simulation, fractional flow reserve estimation


name: coronary CT angiography, anatomical data comparison with fractional flow reserve estimation, interpretation and report


name: myocardial PET, absolute quantitation of perfusion


name: LVEF by 3D ultrasound image segmentation


name: LVEF by M-mode ultrasound and calculation by cube method


name: rectal culture for Chlamydia trachomatis


name: antigen detection for HPV, five or more high-risk types


name: NAA with probe detection for Chlamydia trachomatis DNA in rectum


name: NAA with probe detection for Chlamydia trachomatis rRNA in rectum


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in cervix


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in rectum


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in urine


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in vagina


name: photodynamic therapy by external light provided by health care professional


name: intensive diabetes prevention program individual, online


name: musculoskeletal procedures injection autologous white blood cell concentrate


name: eye surg insert ant segment aqueous drain device internal supraciliary


name: retinal electrode array initial programming


name: mitral valve implantation transcatheter prosthetic


name: mitral valve implantation transcatheter prosthetic percutaneous approach


name: mitral valve implantation transcatheter prosthetic transthoracic exposure


name: preparation of donor lung prior to implantation with cannulation to ex vivo organ perfusion system


name: initiation and monitoring of donor lung organ perfusion system prior to implantation


name: initiation and monitoring of donor lung organ perfusion system prior to implantation, first 2 hours in sterile field


name: initiation and monitoring of donor lung organ perfusion system prior to implantation, each additional hour in sterile field


name: cystourethroscopy with mechanical dilation and therapeutic drug delivery


name: cystourethroscopy with mechanical dilation and therapeutic drug delivery for urethral stricture or stenosis


name: robotic-assisted laparoscopic total hysterectomy


name: robotic-assisted laparoscopic radical hysterectomy


name: debridement of premalignant hyperkeratotic lesion


name: debridement of premalignant hyperkeratotic lesion followed by photodynamic therapy by external light


name: ablative laser treatment fractional resurfacing


name: ablative fractional resurfacing burn or scar


name: ablative fractional resurfacing burn or scar first 100 cm2


name: ablative fractional resurfacing of burn or scar, each additional 100 cm2


name: ablative fractional resurfacing burn/scar 1% body surface area infant/child


name: ablative fractional resurfacing of burn or scar, each additional 1% body surface area of infant/child


name: ablative fractional resurfacing open wound


name: ablative fractional resurfacing open wound first 20 cm2 or less


name: ablative fractional resurfacing of open wound, each additional 20 cm2


name: autologous adipose-derived regenerative cell therapy


name: autologous adipose-derived regenerative cell therapy for scleroderma of hands, multiple injections


name: environment: intermediate care hospital for intellectually disabled


name: acetaminophen + aspirin + dextromethorphan + diphenhydramine


name: acetaminophen + dextromethorphan + phenylephrine + doxylamine + guaifenesin


name: {1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack


name: prothrombin time in control platelet-poor plasma by coagulation assay


name: arterial cord blood PaCO2 adjusted to patient's actual temperature


name: arterial cord blood PaO2 adjusted to patient's actual temperature


name: first and second trimester integrated maternal serum or plasma screening panel


name: first and second trimester integrated maternal interpretation


name: protein electrophoresis panel in serum or plasma


name: albumin / total protein in serum or plasma by electrophoresis


name: alpha 1 globulin/total protein in serum or plasma by electrophoresis


name: alpha 2 globulin/total protein in serum or plasma by electrophoresis


name: beta globulin/total protein in serum or plasma by electrophoresis


name: clozapine and norclozapine panel in serum or plasma


name: tissue transglutaminase IgA antibody in serum


name: tissue transglutaminase IgG antibody in serum


name: 24 hour renal creatinine clearance panel


name: GFR predicted by cystatin-based formula, serum or plasma


name: PTA of right common iliac artery, initial vessel


name: PTA of right common iliac artery, initial vessel, with atherectomy


name: PTA of right common iliac artery, initial vessel, with stent


name: PTA of right common iliac artery, initial vessel, with drug-eluting stent


name: PTA of right common iliac artery, initial vessel, with atherectomy and stent


name: PTA of right common iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right common iliac artery, each additional vessel


name: PTA of right common iliac artery, each additional vessel, with atherectomy


name: PTA of right common iliac artery, each additional vessel, with stent


name: PTA of right common iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right common iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right common iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right external iliac artery, initial vessel


name: PTA of right external iliac artery, initial vessel, with atherectomy


name: PTA of right external iliac artery, initial vessel, with stent


name: PTA of right external iliac artery, initial vessel, with drug-eluting stent


name: PTA of right external iliac artery, initial vessel, with atherectomy and stent


name: PTA of right external iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right external iliac artery, each additional vessel


name: PTA of right external iliac artery, each additional vessel, with atherectomy


name: PTA of right external iliac artery, each additional vessel, with stent


name: PTA of right external iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right external iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right external iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right internal iliac artery, initial vessel


name: PTA of right internal iliac artery, initial vessel, with atherectomy


name: PTA of right internal iliac artery, initial vessel, with stent


name: PTA of right internal iliac artery, initial vessel, with drug-eluting stent


name: PTA of right internal iliac artery, initial vessel, with atherectomy and stent


name: PTA of right internal iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right internal iliac artery, each additional vessel


name: PTA of right internal iliac artery, each additional vessel, with atherectomy


name: PTA of right internal iliac artery, each additional vessel, with stent


name: PTA of right internal iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right internal iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right internal iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left common iliac artery, initial vessel


name: PTA of left common iliac artery, initial vessel, with atherectomy


name: PTA of left common iliac artery, initial vessel, with stent


name: PTA of left common iliac artery, initial vessel, with drug-eluting stent


name: PTA of left common iliac artery, initial vessel, with atherectomy and stent


name: PTA of left common iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left common iliac artery, each additional vessel


name: PTA of left common iliac artery, each additional vessel, with atherectomy


name: PTA of left common iliac artery, each additional vessel, with stent


name: PTA of left common iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left common iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left common iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left external iliac artery, initial vessel


name: PTA of left external iliac artery, initial vessel, with atherectomy


name: PTA of left external iliac artery, initial vessel, with stent


name: PTA of left external iliac artery, initial vessel, with drug-eluting stent


name: PTA of left external iliac artery, initial vessel, with atherectomy and stent


name: PTA of left external iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left external iliac artery, each additional vessel


name: PTA of left external iliac artery, each additional vessel, with atherectomy


name: PTA of left external iliac artery, each additional vessel, with stent


name: PTA of left external iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left external iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left external iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left internal iliac artery, initial vessel


name: PTA of left internal iliac artery, initial vessel, with atherectomy


name: PTA of left internal iliac artery, initial vessel, with stent


name: PTA of left internal iliac artery, initial vessel, with drug-eluting stent


name: PTA of left internal iliac artery, initial vessel, with atherectomy and stent


name: PTA of left internal iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left internal iliac artery, each additional vessel


name: PTA of left internal iliac artery, each additional vessel, with atherectomy


name: PTA of left internal iliac artery, each additional vessel, with stent


name: PTA of left internal iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left internal iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left internal iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right iliac artery, initial vessel


name: PTA of right iliac artery, each additional vessel


name: PTA of left iliac artery, initial vessel


name: PTA of left iliac artery, each additional vessel


name: PTA of right popliteal artery, above knee


name: PTA of right popliteal artery, above knee, initial vessel


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy


name: PTA of right popliteal artery, above knee, initial vessel with stent


name: PTA of right popliteal artery, above knee, initial vessel with drug-eluting stent


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy and stent


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, above knee, additional vessel


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy


name: PTA of right popliteal artery, above knee, additional vessel with stent


name: PTA of right popliteal artery, above knee, additional vessel with drug-eluting stent


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy and stent


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, below knee


name: PTA of right popliteal artery, below knee, initial vessel


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy


name: PTA of right popliteal artery, below knee, initial vessel with stent


name: PTA of right popliteal artery, below knee, initial vessel with drug-eluting stent


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy and stent


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, below knee, additional vessel


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy


name: PTA of right popliteal artery, below knee, additional vessel with stent


name: PTA of right popliteal artery, below knee, additional vessel with drug-eluting stent


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy and stent


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, above knee


name: PTA of left popliteal artery, above knee, initial vessel


name: PTA of left popliteal artery, above knee, initial vessel with atherectomy


name: PTA of left popliteal artery, initial vessel with stent


name: PTA of left popliteal artery, initial vessel with drug-eluting stent


name: PTA of left popliteal artery, initial vessel with atherectomy and stent


name: PTA of left popliteal artery, initial vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, above knee, additional vessel


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy


name: PTA of left popliteal artery, above knee, additional vessel with stent


name: PTA of left popliteal artery, above knee, additional vessel with drug-eluting stent


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy and stent


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, below knee


name: PTA of left popliteal artery, below knee, initial vessel


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy


name: PTA of left popliteal artery, below knee, initial vessel with stent


name: PTA of left popliteal artery, below knee, initial vessel with drug-eluting stent


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy and stent


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, below knee, additional vessel


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy


name: PTA of left popliteal artery, below knee, additional vessel with stent


name: PTA of left popliteal artery, below knee, additional vessel with drug-eluting stent


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy and stent


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, initial vessel


name: PTA of left popliteal artery, initial vessel


name: PTA of popliteal artery, additional vessel


name: PTA of right popliteal artery, additional vessel


name: PTA of left popliteal artery, additional vessel


name: PTA of right tibioperoneal, initial vessel


name: PTA of right tibioperoneal, initial vessel, with atherectomy


name: PTA of right tibioperoneal, initial vessel, with stent


name: PTA of right tibioperoneal, initial vessel, with drug-eluting stent


name: PTA of right tibioperoneal, initial vessel, with atherectomy and stent


name: PTA of right tibioperoneal, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right tibioperoneal, additional vessel


name: PTA of right tibioperoneal, additional vessel, with atherectomy


name: PTA of right tibioperoneal, additional vessel, with stent


name: PTA of right tibioperoneal, additional vessel, with drug-eluting stent


name: PTA of right tibioperoneal, additional vessel, with atherectomy and stent


name: PTA of right tibioperoneal, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left tibioperoneal, initial vessel


name: PTA of left tibioperoneal, initial vessel, with atherectomy


name: PTA of left tibioperoneal, initial vessel, with stent


name: PTA of left tibioperoneal, initial vessel, with drug-eluting stent


name: PTA of left tibioperoneal, initial vessel, with atherectomy and stent


name: PTA of left tibioperoneal, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left tibioperoneal, each additional vessel


name: PTA of left tibioperoneal, each additional vessel, with atherectomy


name: PTA of left tibioperoneal, each additional vessel, with stent


name: PTA of left tibioperoneal, each additional vessel, with drug-eluting stent


name: PTA of left tibioperoneal, each additional vessel, with atherectomy and stent


name: PTA of left tibioperoneal, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right peroneal artery, initial vessel


name: PTA of right peroneal artery, initial vessel, with atherectomy


name: PTA of right peroneal artery, initial vessel, with stent


name: PTA of right peroneal artery, initial vessel, with drug-eluting stent


name: PTA of right peroneal artery, initial vessel, with atherectomy and stent


name: PTA of right peroneal artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right peroneal artery, additional vessel


name: PTA of right peroneal artery, additional vessel, with atherectomy


name: PTA of right peroneal artery, additional vessel, with stent


name: PTA of right peroneal artery, additional vessel, with drug-eluting stent


name: PTA of right peroneal artery, additional vessel, with atherectomy and stent


name: PTA of right peroneal artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left peroneal artery, initial vessel


name: PTA of left peroneal artery, initial vessel, with atherectomy


name: PTA of left peroneal artery, initial vessel, with stent


name: PTA of left peroneal artery, initial vessel, with drug-eluting stent


name: PTA of left peroneal artery, initial vessel, with atherectomy and stent


name: PTA of left peroneal artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left peroneal artery, each additional vessel


name: PTA of left peroneal artery, each additional vessel, with atherectomy


name: PTA of left peroneal artery, each additional vessel, with stent


name: PTA of left peroneal artery, additional vessel, with drug-eluting stent


name: PTA of left peroneal artery, each additional vessel, with atherectomy and stent


name: PTA of left peroneal artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of peroneal artery, each additional vessel


name: Borrelia burgdorferi panel in serum by immunoblot


name: Borrelia burgdorferi IgG panel in serum by immunoblot


name: Borrelia burgdorferi IgM panel in serum by immunoblot


name: hepatitis B core and surface antibody, surface antigen panel in serum


name: hepatitis C FibroSURE (TM) panel in serum or plasma


name: opiates panel in meconium, confirmatory method


name: protein electrophoresis and immunoglobulins panel in serum


name: 25-hydroxyvitamin D2 + 25-hydroxyvitamin D3 in serum or plasma


name: calcidiol + calciferol in serum or plasma, interpretation


name: beta 1 globulin in serum or plasma by electrophoresis


name: beta 1 globulin / total protein in serum or plasma by electrophoresis


name: beta 2 globulin in serum or plasma by electrophoresis


name: beta 2 globulin / total protein in serum or plasma by electrophoresis


name: gamma globulin/total protein in serum or plasma by electrophoresis


name: monoclonal protein / total protein in serum or plasma by electrophoresis


name: lipoprotein fractions in serum or plasma by electrophoresis, interpretation


name: renal creatinine clearance 24 hour panel adjusted for body surface area


name: creatinine and GFR predicted panel in serum or plasma


name: serum immunoblot for Borrelia burgdorferi antibody


name: serum immunoblot for Borrelia burgdorferi IgG antibody


name: serum immunoblot for Borrelia burgdorferi 18kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 23kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 28kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 30kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 39kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 41kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 45kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 58kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 66kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 93kD IgG antibody


name: Borrelia burgdorferi IgG antibody band pattern interpretation in serum by immunoblot


name: serum immunoblot for Borrelia burgdorferi IgM antibody


name: serum immunoblot for Borrelia burgdorferi 23kD IgM antibody


name: serum immunoblot for Borrelia burgdorferi 39kD IgM antibody


name: serum immunoblot for Borrelia burgdorferi 41kD IgM antibody


name: Borrelia burgdorferi IgM antibody band pattern interpretation in serum by immunoblot


name: serum immunoblot for Borrelia burgdorferi IgG + IgM antibody


name: PTA of right common femoral artery, initial vessel


name: PTA of right common femoral artery, initial vessel, with atherectomy


name: PTA of right common femoral artery, initial vessel, with stent


name: PTA of right common femoral artery, initial vessel, with drug-eluting stent


name: PTA of right common femoral artery, initial vessel, with atherectomy and stent


name: PTA of right common femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right common femoral artery, additional vessel


name: PTA of right common femoral artery, additional vessel, with atherectomy


name: PTA of right common femoral artery, additional vessel, with stent


name: PTA of right common femoral artery, additional vessel, with drug-eluting stent


name: PTA of right common femoral artery, additional vessel, with atherectomy and stent


name: PTA of right common femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right profunda femoral artery, initial vessel


name: PTA of right profunda femoral artery, initial vessel, with atherectomy


name: PTA of right profunda femoral artery, initial vessel, with stent


name: PTA of right profunda femoral artery, initial vessel, with drug-eluting stent


name: PTA of right profunda femoral artery, initial vessel, with atherectomy and stent


name: PTA of right profunda femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right profunda femoral artery, additional vessel


name: PTA of right profunda femoral artery, additional vessel, with atherectomy


name: PTA of right profunda femoral artery, additional vessel, with stent


name: PTA of right profunda femoral artery, additional vessel, with drug-eluting stent


name: PTA of right profunda femoral artery, additional vessel, with atherectomy and stent


name: PTA of right profunda femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right superficial femoral artery, initial vessel


name: PTA of right superficial femoral artery, initial vessel, with atherectomy


name: PTA of right superficial femoral artery, initial vessel, with stent


name: PTA of right superficial femoral artery, initial vessel, with drug-eluting stent


name: PTA of right superficial femoral artery, initial vessel, with atherectomy and stent


name: PTA of right superficial femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right superficial femoral artery, additional vessel


name: PTA of right superficial femoral artery, additional vessel, with atherectomy


name: PTA of right superficial femoral artery, additional vessel, with stent


name: PTA of right superficial femoral artery, additional vessel, with drug-eluting stent


name: PTA of right superficial femoral artery, additional vessel, with atherectomy and stent


name: PTA of right superficial femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left common femoral artery, initial vessel


name: PTA of left common femoral artery, initial vessel, with atherectomy


name: PTA of left common femoral artery, initial vessel, with stent


name: PTA of left common femoral artery, initial vessel, with drug-eluting stent


name: PTA of left common femoral artery, initial vessel, with atherectomy and stent


name: PTA of left common femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left common femoral artery, additional vessel


name: PTA of left common femoral artery, additional vessel, with atherectomy


name: PTA of left common femoral artery, additional vessel, with stent


name: PTA of left common femoral artery, additional vessel, with drug-eluting stent


name: PTA of left common femoral artery, additional vessel, with atherectomy and stent


name: PTA of left common femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left profunda femoral artery, initial vessel


name: PTA of left profunda femoral artery, initial vessel, with atherectomy


name: PTA of left profunda femoral artery, initial vessel, with stent


name: PTA of left profunda femoral artery, initial vessel, with drug-eluting stent


name: PTA of left profunda femoral artery, initial vessel, with atherectomy and stent


name: PTA of left profunda femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left profunda femoral artery, additional vessel


name: PTA of left profunda femoral artery, additional vessel, with atherectomy


name: PTA of left profunda femoral artery, additional vessel, with stent


name: PTA of left profunda femoral artery, additional vessel, with drug-eluting stent


name: PTA of left profunda femoral artery, additional vessel, with atherectomy and stent


name: PTA of left profunda femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left superficial femoral artery, initial vessel